QGEN
Qiagen N.V.
Company Overview
| Mkt Cap | $10.36B | Price | $45.73 |
| Volume | 1.05M | Change | -2.39% |
| P/E Ratio | 124.0 | Open | $46.28 |
| Revenue | $2.0B | Prev Close | $46.85 |
| Net Income | $83.6M | 52W Range | $37.63 - $51.88 |
| Div Yield | 0.25% | Target | $52.18 |
| Overall | 53 | Value | -- |
| Quality | 44 | Technical | 63 |
No chart data available
Stock Overview
Updated DailyQiagen N.V. (QGEN) is a leading Healthcare company in the Diagnostics & Research industry, currently trading at $46.85 with a market capitalization of $10.36 billion. The stock is positioned in the upper portion of its trading range, demonstrating below-average quality metrics with a MarketXLS quality score of 44.
Today's trading session shows QGEN with a volume of 1.26 million shares. The stock opened down 0.00% from yesterday's close of $46.33. Current analyst estimates project earnings of $2.34 per share for this year, with next year targeting $2.49.
QGEN demonstrates positive technical signals based on technical analysis. The company trades on the NYE exchange and operates alongside industry peers including TMO, HOLX, BDX, GE, TECH.
Key investment considerations for QGEN include average overall investment profile. The company offers a dividend yield of 0.25% and analyst price targets suggest potential upside of 11.4%. The stock shows neutral valuation metrics based on valuation analysis.
Analysis generated on November 3, 2025 at 04:51 PM
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | QGEN | $45.73 | -2.4% | 1.05M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |